Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTNNB1 | P35222 | 19/20 | 0.61 |
| ▸ | TCF7L2 | Q9NQB0 | 19/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4738259 | 0.93 | CTNNB1 (0.69) | CTNNB1TCF7L2RAB9ASMN1; SMN2 | |
| SCHEMBL4740153 | 0.90 | CTNNB1 (0.76) | CTNNB1TCF7L2 | |
| Hydrochloric Acid SCHEMBL4735277 | 0.89 | CTNNB1 (0.75) | CTNNB1TCF7L2 | |
| SCHEMBL4166958 | 0.84 | CTNNB1 (0.82) | CTNNB1TCF7L2 | |
| SCHEMBL4739672 | 0.83 | CTNNB1 (0.84) | CTNNB1TCF7L2 | |
| SCHEMBL4737801 | 0.82 | CTNNB1 (0.55) | CTNNB1TCF7L2RAB9ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4736475 | 0.82 | CTNNB1 (0.83) | CTNNB1TCF7L2 | |
| SCHEMBL4167914 | 0.81 | CTNNB1 (0.81) | CTNNB1TCF7L2RAB9ASMN1; SMN2 | |
| SCHEMBL4167909 | 0.81 | CTNNB1 (0.81) | CTNNB1TCF7L2RAB9ASMN1; SMN2 | |
| SCHEMBL4170966 | 0.80 | CTNNB1 (0.79) | CTNNB1TCF7L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008086462-A2 | AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS | WYETH (US) | 2008-07-17 | — | — | WO | disclosed |